Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-8500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions ; day:2 ; month:2 ; year:2019 ; pages:1-13
Hormones and cancer ; (2.2.2019), 1-13
- Urheber
-
Rodriguez, Adriana C.
Blanchard, Zannel
Maurer, Kathryn A.
Gertz, Jason
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-019-0358-9
- URN
-
urn:nbn:de:101:1-2019043019313268700220
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rodriguez, Adriana C.
- Blanchard, Zannel
- Maurer, Kathryn A.
- Gertz, Jason
- SpringerLink (Online service)
Ähnliche Objekte (12)
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
Estrogen mediated expression of nucleophosmin 1 in human endometrial carcinoma clinical stages through estrogen receptor-α signaling
Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers
Magnetic resonance spectroscopy associations with clinicopathologic features of estrogen-dependent endometrial cancer
Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism
Estrogen receptor alpha gene polymorphism and endometrial cancer risk – a case-control study
Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer
Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells
Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer
Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line
Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer
Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
Estrogen mediated expression of nucleophosmin 1 in human endometrial carcinoma clinical stages through estrogen receptor-α signaling
Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers
Magnetic resonance spectroscopy associations with clinicopathologic features of estrogen-dependent endometrial cancer
Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism
Estrogen receptor alpha gene polymorphism and endometrial cancer risk – a case-control study
Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer
Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells
Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer
Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line
Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer
Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
Estrogen mediated expression of nucleophosmin 1 in human endometrial carcinoma clinical stages through estrogen receptor-α signaling
Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers
Magnetic resonance spectroscopy associations with clinicopathologic features of estrogen-dependent endometrial cancer
Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism
Estrogen receptor alpha gene polymorphism and endometrial cancer risk – a case-control study
Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer
Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells
Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer
Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line
Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer